Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review.

By J. Critchley, S. Capewell. Journal of the American Medical Association (JAMA), 2003

1,160 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Evaluation of the Quality of Prognosis Studies in Systematic Reviews (2006, background): “Other reviews did not find an association between selection bias and outcome (37, 110, 111, 167, 170, 173, 174).”
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). (2007, background): “Given these associations, smoking cessation has been a cornerstone of the management of PAD as is the case for CAD.(35) Other drugs for smoking cessation are becoming available.”
Social Relationships and Mortality Risk: A Meta-analytic Review (2010, neutral): “The effect sizes were estimated from meta analyses: ; A = Shavelle, Paculdo, Strauss, and Kush, 2008 [205]; B = Critchley and Capewell, 2003 [206]; C = Holman, English, Milne, and Winter, 1996 [207]; D = Fine, Smith, Carson, Meffe, Sankey, Weissfeld, Detsky, and Kapoor, 1994 [208]; E = Taylor, Brown”